Spectrum Equity is proud to announce Jeff Haywood and Steve LeSieur have been recognized by GrowthCap for their contributions as top growth equity investors in healthcare. Together they lead Spectrum’s investment activity in healthcare, focusing on high growth Internet-enabled software and information services companies serving consumers and enterprises in all parts of the healthcare market. They serve key roles in establishing and fostering long-standing partnerships with CEOs and management teams and help them accelerate growth through product innovation as well as economic and market opportunity expansion. They have also helped guide management teams through several successful exits to strategic acquirers, financial sponsors and the public markets. Learn more about our healthcare investments here.
Jeff Haywood and Steve LeSieur lead Spectrum Equity’s investment activity in healthcare, focusing on high growth Internet-enabled software and information services companies serving all parts of the healthcare market.
Steve joined Spectrum in 2005 and currently serves on the following healthcare company boards including GoodRx (NASDAQ: GDRX) and Payer Compass and was previously involved with Definitive Healthcare, MedHOK (acquired by Hearst Health), HealthMEDX (acquired by NetSmart), Passport Health Communications (acquired by Experian) and QTC Management (acquired by Lockheed Martin).
Jeff joined the firm in 2007 and currently serves on the following healthcare company boards including Definitive Healthcare, Payer Compass, RxVantage and Verisys. He also led Spectrum’s recent investment in PWNHealth and subsequent sale to Everlywell, where he continues as a board observer. Jeff was previously involved with GoodRx (NASDAQ: GDRX), MedHOK (acquired by Hearst Health), Net Health (acquired by The Carlyle Group), and Passport Health Communications (acquired by Experian).
“Spectrum Equity is committed to fostering long-standing partnerships with the founders and entrepreneurs building today’s market leading digital health companies. It is incredibly rewarding to support the efforts of management teams addressing the highly complex issues that exist, and are often unique, in healthcare. We believe the ongoing evolution of connected software, data and analytics will continue to have a massive impact on healthcare both in terms of increasing access to care and improving outcomes.” – Steve LeSieur & Jeff Haywood
GrowthCap is pleased to announce The Top 25 Healthcare Investors of 2021. In our inaugural year for these awards, we wanted to bring forth and recognize not only the most experienced and talented investors in healthcare but also those that help advance innovation across the sector. Whether in healthcare software, healthcare services, medical technologies, biotechnology, the connected patient experience, or other areas, these accomplished individuals have demonstrated a deep commitment to healthcare and as a result have succeeded both from a business standpoint as well as in having significant societal impact.
This year’s awardees were nominated by their firms, portfolio companies, healthcare industry colleagues, and/or peers at other investment firms. Awardee selections and rankings were based on deal experience and track record, strategic and operational capabilities provided to portfolio companies, unique and differentiated attributes, as well as contributions to charitable work and overall industry advancement. Healthcare plays a crucial role in the quality of our lives, underpins all other business and economic activity, and ultimately determines the state of our world. Please join us in recognizing and celebrating the achievements of The Top 25 Healthcare Investors of 2021.
See the full listing of the awardees here.